المؤلفون: Yousif, Laura I, Screever, Elles M, Versluis, Daniëlle, Aboumsallem, Joseph Pierre, Nierkens, Stefan, Manintveld, Olivier C, de Boer, Rudolf A, Meijers, Wouter C

المساهمون: CDL Nanomedicine, CTI Research, Cancer, Infection & Immunity

مصطلحات موضوعية: Antineoplastic Agents, Immunological/adverse effects, Cardiovascular System, Female, Humans, Immune Checkpoint Inhibitors/adverse effects, Myocarditis/chemically induced, Neoplasms, Risk Factors, Pericarditis, ICI, Myocarditis, Vasculitis, Oncology, Journal Article, Review, Research Support, Non-U.S. Gov't

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/451971Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/451971Test

المساهمون: Shanu Modi, William Jacot, Toshinari Yamashita, Joohyuk Sohn, Maria Vidal, Eriko Tokunaga, Junji Tsurutani, Naoto T Ueno, Aleix Prat, Yee Soo Chae, Keun Seok Lee, Naoki Niikura, Yeon Hee Park, Binghe Xu, Xiaojia Wang, Miguel Gil-Gil, Wei Li, Jean-Yves Pierga, Seock-Ah Im, Halle C F Moore, Hope S Rugo, Rinat Yerushalmi, Flora Zagouri, Andrea Gombos, Sung-Bae Kim, Qiang Liu, Ting Luo, Cristina Saura, Peter Schmid, Tao Sun, Dhiraj Gambhire, Lotus Yung, Yibin Wang, Jasmeet Singh, Patrik Vitazka, Gerold Meinhardt, Nadia Harbeck, David A Cameron, DESTINY-Breast04 Trial Investigators, Sohn, Joo Hyuk

مصطلحات موضوعية: Antibodies, Monoclonal, Humanized / adverse effects, Humanized / therapeutic use, Antineoplastic Agents, Immunological* / adverse effects, Immunological* / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Breast Neoplasms* / drug therapy, Breast Neoplasms* / genetics, Breast Neoplasms* / metabolism, Breast Neoplasms* / secondary, Camptothecin / analogs & derivatives, Disease Progression, Female, Humans, Immunoconjugates / adverse effects, Immunoconjugates / therapeutic use, Immunohistochemistry, Receptor, ErbB-2* / analysis, ErbB-2* / biosynthesis, ErbB-2* / genetics, Trastuzumab* / adverse effects, Trastuzumab* / therapeutic use

العلاقة: NEW ENGLAND JOURNAL OF MEDICINE; J02371; OAK-2022-06757; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191707Test; T202205359; NEW ENGLAND JOURNAL OF MEDICINE, Vol.387(1) : 9-20, 2022-07

الإتاحة: https://doi.org/10.1056/NEJMoa2203690Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191707Test

المساهمون: Byoung Chul Cho, Enriqueta Felip, Hidetoshi Hayashi, Michael Thomas, Shun Lu, Benjamin Besse, Tao Sun, Melissa Martinez, Seema N Sethi, S Martin Shreeve, Alexander I Spira, Cho, Byoung Chul

مصطلحات موضوعية: Acrylamides / adverse effects, Acrylamides / therapeutic use, Adolescent, Adult, Aniline Compounds / adverse effects, Aniline Compounds / therapeutic use, Antibodies, Bispecific / adverse effects, Bispecific / therapeutic use, Antineoplastic Agents, Immunological / adverse effects, Immunological / therapeutic use, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / pathology, ErbB Receptors / antagonists & inhibitors, ErbB Receptors / genetics, Humans, Lung Neoplasms / drug therapy, Lung Neoplasms / genetics, Lung Neoplasms / pathology, Morpholines / adverse effects, Morpholines / therapeutic use, Mutation, Neoplasm Metastasis, Protein Kinase Inhibitors / adverse effects, Protein Kinase Inhibitors / therapeutic use

العلاقة: FUTURE ONCOLOGY; J00914; OAK-2022-05607; https://ir.ymlib.yonsei.ac.kr/handle/22282913/191236Test; T202205272; FUTURE ONCOLOGY, Vol.18(6) : 639-647, 2022-02

الإتاحة: https://doi.org/10.2217/fon-2021-0923Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/191236Test

المؤلفون: Coukos, A., Vionnet, J., Obeid, M., Bouchaab, H., Peters, S., Latifyan, S., Wicky, A., Michielin, O., Chtioui, H., Moradpour, D., Fasquelle, F., Sempoux, C., Fraga, M.

المصدر: Journal for immunotherapy of cancer, vol. 10, no. 10, pp. e005635

مصطلحات موضوعية: Humans, Antineoplastic Agents, Immunological/adverse effects, Immune Checkpoint Inhibitors/adverse effects, Immunotherapy/adverse effects, Neoplasms, Immune System Diseases/chemically induced, Liver Diseases/etiology, Liver Diseases/drug therapy, Hepatitis, Autoimmune/etiology, Autoimmune/drug therapy, CTLA-4 antigen, autoimmunity, cytotoxicity, immunologic, immunotherapy, programmed cell death 1 receptor

وصف الملف: application/pdf

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36283734; info:eu-repo/semantics/altIdentifier/eissn/2051-1426; info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_F836C2B098EA1; https://serval.unil.ch/notice/serval:BIB_F836C2B098EATest; urn:issn:2051-1426; https://serval.unil.ch/resource/serval:BIB_F836C2B098EA.P001/REF.pdfTest; http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F836C2B098EA1Test

الإتاحة: https://doi.org/10.1136/jitc-2022-005635Test
https://serval.unil.ch/notice/serval:BIB_F836C2B098EATest
https://serval.unil.ch/resource/serval:BIB_F836C2B098EA.P001/REF.pdfTest
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F836C2B098EA1Test

المؤلفون: Duong, Sophie Lan-Linh, Prüß, Harald

المصدر: Neurotherapeutics 19(3), 848-863 (2022). doi:10.1007/s13311-022-01184-0

مصطلحات موضوعية: info:eu-repo/classification/ddc/610, Antineoplastic Agents, Immunological: adverse effects, Humans, Immune Checkpoint Inhibitors, Immunotherapy: adverse effects, Immunotherapy: methods, Melanoma: chemically induced, Syndrome, Autoantibodies, Biologicals, Neurological adverse events, Novel immunotherapies, Paraneoplastic neurological syndromes

جغرافية الموضوع: DE

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/pmid:35043373; info:eu-repo/semantics/altIdentifier/issn/1545-5351; info:eu-repo/semantics/altIdentifier/issn/1545-5343; info:eu-repo/semantics/altIdentifier/issn/1933-7213; info:eu-repo/semantics/altIdentifier/issn/1878-7479; https://pub.dzne.de/record/163426Test; https://pub.dzne.de/search?p=id:%22DZNE-2022-00186%22Test

الإتاحة: https://doi.org/10.1007/s13311-022-01184-0Test
https://pub.dzne.de/record/163426Test
https://pub.dzne.de/search?p=id:%22DZNE-2022-00186%22Test

المؤلفون: Holmstroem, Rikke Boedker, Dahl, Emilie Kristine, Helms, Morten, Nielsen, Henrik Vedel, Andersen, Janne Bayer, Bjerrum, Jacob Tveiten, Svane, Inge Marie, Ellebaek, Eva, Seidelin, Jakob Benedict

المصدر: Holmstroem , R B , Dahl , E K , Helms , M , Nielsen , H V , Andersen , J B , Bjerrum , J T , Svane , I M , Ellebaek , E & Seidelin , J B 2022 , ' Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis : case report ' , BMJ Open Gastroenterology , vol. 9 , no. 1 , e000989 . https://doi.org/10.1136/bmjgast-2022-000989Test

مصطلحات موضوعية: Humans, Fecal Microbiota Transplantation/adverse effects, Antineoplastic Agents, Immunological/adverse effects, Enterocolitis/chemically induced, Colitis/therapy

وصف الملف: application/pdf

الإتاحة: https://doi.org/10.1136/bmjgast-2022-000989Test
https://curis.ku.dk/portal/da/publications/tofacitinib-and-faecal-microbiota-transplantation-in-treating-checkpoint-inhibitorinduced-enterocolitisTest(9a254421-b5ef-4cb4-83ad-938ac9ad0619).html
https://curis.ku.dk/ws/files/334023102/e000989.full.pdfTest

المؤلفون: Taugner, Julian, Käsmann, Lukas, Eze, Chukwuka, Rühle, Alexander, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Manapov, Farkhad

المصدر: http://lobid.org/resources/99370674913906441Test#!, 39(4):1189-1196.

مصطلحات موضوعية: Aged [MeSH], Progression-Free Survival [MeSH], Treatment pattern, Neoplasm Staging [MeSH], Male [MeSH], Antibodies, Monoclonal/administration, PD-L1 inhibitor, Short Report, Carcinoma, Non-Small-Cell Lung/pathology [MeSH], Antineoplastic Agents, Immunological/adverse effects [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Lung Neoplasms/therapy [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Positron Emission Tomography Computed Tomography [MeSH], Checkpoint inhibition, Middle Aged [MeSH], Chemoradiotherapy, Non-small cell lung cancer, Lung Neoplasms/pathology [MeSH], Immunological/administration, Monoclonal/adverse effects [MeSH], Non-Small-Cell Lung/therapy [MeSH], Chemoradiotherapy [MeSH]

العلاقة: https://repository.publisso.de/resource/frl:6444967Test; https://doi.org/10.1007/s10637-021-01091-9Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280025Test/

الإتاحة: https://doi.org/10.1007/s10637-021-01091-9Test
https://repository.publisso.de/resource/frl:6444967Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280025Test/

المؤلفون: Taugner, Julian, Käsmann, Lukas, Karin, Monika, Eze, Chukwuka, Flörsch, Benedikt, Guggenberger, Julian, Li, Minglun, Tufman, Amanda, Reinmuth, Niels, Duell, Thomas, Belka, Claus, Manapov, Farkhad

المصدر: http://lobid.org/resources/99370674913906441Test#!, 40(1):163-171.

مصطلحات موضوعية: Age Factors [MeSH], Aged [MeSH], Antibodies, Monoclonal/therapeutic use [MeSH], Nivolumab/adverse effects [MeSH], Neoplasm Staging [MeSH], Male [MeSH], Monoclonal/administration, Immune Checkpoint Inhibitors/adverse effects [MeSH], Immune Checkpoint Inhibitors/administration, Chemoradiotherapy/adverse effects [MeSH], Sex Factors [MeSH], Short Report, Carcinoma, Non-Small-Cell Lung/pathology [MeSH], Antineoplastic Agents, Immunological/adverse effects [MeSH], Female [MeSH], Lung Neoplasms/therapy [MeSH], Adult [MeSH], Humans [MeSH], Prospective Studies [MeSH], Tumor volume, Chemoradiotherapy/methods [MeSH], Survival Analysis [MeSH], Checkpoint inhibition, Middle Aged [MeSH], Prediction, Immune Checkpoint Inhibitors/therapeutic use [MeSH], Chemoradiotherapy

العلاقة: https://repository.publisso.de/resource/frl:6444959Test; https://doi.org/10.1007/s10637-021-01143-0Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763767Test/

الإتاحة: https://doi.org/10.1007/s10637-021-01143-0Test
https://repository.publisso.de/resource/frl:6444959Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763767Test/

المؤلفون: Antoniou, Sofia, Bazazo, Georgios, Röckl, Ludwig, Papadakis, Marios, Berg, Christian

المصدر: http://lobid.org/resources/99370673925006441Test#!, 21(1):191.

مصطلحات موضوعية: Antineoplastic Agents, Immunological/adverse effects [MeSH], Hypophysitis, Skin melanoma, Withholding Treatment/statistics, Humans [MeSH], Middle Aged [MeSH], Skin Neoplasms/drug therapy [MeSH], Skin Neoplasms/pathology [MeSH], Nivolumab/adverse effects [MeSH], Hypophysitis/pathology [MeSH], Hypophysitis/chemically induced [MeSH], Nivolumab, Age of Onset [MeSH], Male [MeSH], Pituitary and Neuroendocrinology, Melanoma/pathology [MeSH], Prognosis [MeSH], Cancer immunotherapy, Melanoma/drug therapy [MeSH], Case Report

العلاقة: https://repository.publisso.de/resource/frl:6465383Test; https://doi.org/10.1186/s12902-021-00854-yTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454065Test/

الإتاحة: https://doi.org/10.1186/s12902-021-00854-yTest
https://repository.publisso.de/resource/frl:6465383Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454065Test/

المساهمون: Keunchil Park, Eric B Haura, Natasha B Leighl, Paul Mitchell, Catherine A Shu, Nicolas Girard, Santiago Viteri, Ji-Youn Han, Sang-We Kim, Chee Khoon Lee, Joshua K Sabari, Alexander I Spira, Tsung-Ying Yang, Dong-Wan Kim, Ki Hyeong Lee, Rachel E Sanborn, José Trigo, Koichi Goto, Jong-Seok Lee, James Chih-Hsin Yang, Ramaswamy Govindan, Joshua M Bauml, Pilar Garrido, Matthew G Krebs, Karen L Reckamp, John Xie, Joshua C Curtin, Nahor Haddish-Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E Knoblauch, Byoung Chul Cho, Cho, Byoung Chul

مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Bispecific / administration & dosage, Bispecific / adverse effects, Bispecific / pharmacokinetics, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, Immunological / pharmacokinetics, Carcinoma, Non-Small-Cell Lung / drug therapy, Non-Small-Cell Lung / genetics, Non-Small-Cell Lung / secondary, Diarrhea / chemically induced, Disease Progression, Drug Eruptions / etiology, ErbB Receptors / genetics, Exons, Female, Humans, Hypokalemia / chemically induced, Injection Site Reaction / etiology, Lung Neoplasms / drug therapy, Lung Neoplasms / genetics, Lung Neoplasms / pathology, Male, Middle Aged, Mutagenesis

العلاقة: JOURNAL OF CLINICAL ONCOLOGY; J01331; OAK-2021-10033; https://ir.ymlib.yonsei.ac.kr/handle/22282913/187654Test; T202125019; JOURNAL OF CLINICAL ONCOLOGY, Vol.39(30) : 3391-3402, 2021-10

الإتاحة: https://doi.org/10.1200/JCO.21.00662Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/187654Test